Trailblazer Interviews

1. Right To Play, Right To Win: Boreal's Business Strategy Story 7/30/2026

   New cell and gene therapy clinical breakthroughs & manufacturing innovations are emerging quickly in a field already characterized by scientific acceleration. It is awfully difficult for CDMOs to effectively communicate their capabilities, let alone establish a new brand in this space. Enter Boreal Biomanufacturing! Eric Lee, General Manger, shares his and Boreal’s story, the challenges they faced, and the strategy they used to develop their new brand.

2. AI & Marketing Are Merging To Create A New Wild West In B2B 7/15/2026

   Artur Tkachev and Seth Preston, Co-Founders of Inf//uent Life Sciences Marketing, join Perry Rearick for the latest edition of the Trailblazers. Disapointing results have B2B solution providers questioning the effectiveness of traditional digital marketing, like email and organic website traffic. Vast amounts of time and resources are wasted trying to address the symptoms and there is little progress on addressing the real underlying problems. The game has changed and B2B buying teams supported by AI agents are operating differently. Sellers must adapt!

3. The Catalent Story With John Chiminski 6/18/2026

   The story of Catalent is one for the ages, an epic tale of growth and the establishment of what we now know as the modern pharmaceutical contract development and manufacturing organization. John Chiminski served as the CEO for fourteen extraordinary years and tells the Catalent story in this episode of the Trailblazers.

4. Why Start-Ups Fail And What Business Leaders Can Do About It 6/4/2026

   Claire Martel is Co-Founder, CEO and President of Murdock-Martell, a finance, accounting and human resources firm that works with some of the most innovative life sciences and technology startups. In this edition of the Trailblazers, she shares her insights into the root causes leading to start-up failure and what innovators should do to avoid them.

5. Real B2B Marketing, No Artificial Ingredients 5/27/2026

   Greg Ippolito, President & Creative Director at Ippolito Media Arts, IMA, is back in this episode of the Trailblazers. He speaks about a new type of silo that is appearing in B2B solution provider companies that results in fragmented marketing plans and has businesses questioning their ROI, and the ever-growing B2B buyer team.

6. Special Edition - CEO Roundtable 4/2/2026

   Rick Hancock, CEO, Argonaut Manufacturing Services; Tim Lowery, CEO, KBI Biopharma & President, JSR Life Sciences; & Tim Mitchell, CEO Sentry Biopharma Services join me for this edition of the Trailblazers to talk about the tri-partnership they have formed, the trends they expect in the pharma industry this year and beyond, and they also offer some sage advice on executive leadership.

7. Joseph Carleone's Touchstones Of Leadership 3/20/2026

   An interview with Joseph Carleone, acclaimed business leader. Mr. Carleone has spent most of his life in executive leadership positions from companies in the defense industry to chemicals, pharmaceuticals, food and cosmetics. In those 45-plus years he experienced significant change in technology, market shifts, and the nature of the workforce. However, he lived and led by a consistent set of principles and he shares some of those with us in this interview.

8. Business Development - Modern Best Practices 3/6/2026

   An interview with Susan Lynch-Smith, Head of Business Development, Douglas CDMO. Sue shares her 30 years of experience in B2B life sciences including the ever-evolving relationship between buyer and solution provider, the importance of empathy, account based marketing, how to discern real opportunities, and her optimism for 2026.

9. Commercializing Innovation With Olliver Stauffer, CEO Of Packaging Technologies & Inspection, PTI 2/20/2026

   It isn't easy to transform innovations into a sustainable commercial business, PTI has done it and continues to do so. In this discussion with Oliver Stauffer, their CEO, we discuss the importance of packaging which is the last defense in protecting life sciences products as they make their way to patients and consumers. We also talk about creating and sustaining a culture of innovation and the need for regulatory clarity, now more than ever, from FDA.

10. Being A B2B Media Company In The Modern Information Age 2/9/2026

    An interview with Matt Pillar, Vice President of Editorial & Content, Life Science Connect. Matt talks about what it takes to be a modern B2B media company, how it's done at Life Science Connect, and their Follow Your Reader Strategy.